The pharmaceutical unit dose packaging market is expected to experience a change in its operations, as manufacturers are focusing towards increasing productivity through integration of automation systems, as per a study by Future Market Insights (FMI). According to the report, the market will surpass US$ 26.10 Bn by 2021, registering a double-digit year-on-year (Y-o-Y) growth between 2020 and 2021.
Get Sample of the report : https://www.futuremarketinsights.com/reports/sample/rep-gb-5236
The dynamic shift from manual to automatic packing lines is in turn expected to increase process efficiency and reduce dependence on the workforce, making it a cost-effective proposition in the long run. Rising demand for prefilled syringes for vaccination programs is expected to be a key trend, which would positively affect the pharmaceutical unit dose packaging market.
Automated packaging lines are also multitasking, which covers numerous steps of the packaging process such as forming, filling, sealing and labeling into single step. The designers of packaging line automation systems are prioritizing the design of human-machine interfaces (HMIs) to streamline processes. These enhanced HMI can sort it simpler for operators and managers to access information related to specific packaging production line.
The above trend is expected to be backed by increasing availability of biotechnology products with specific requirements for packaging such as prefilled syringes and single-use vials. Vials and prefilled syringes are two of the most common forms of pharmaceutical unit dose packaging, typically preferred in clinical research and diagnostic centers.
Vials and blisters have been identified as the most prominently used products in the pharmaceutical unit dose packaging market. Manufactures are vigorously ramping up for their facilities of vials production in anticipation of the demand for COVID-19 vaccine supply from all over the world. Thus, the segment is projected to expand 5.7x its current value during the forecast period.
Key Takeaways from Pharmaceutical Unit Dose Packaging Market
- Pharmaceutical unit dose packaging sales will surge at 14.7% CAGR between 2021 and 2031
- The presence of several leading players has enabled the U.S. account for over 87% of sales in North America in 2021
- Rising research and development initiatives enabling the U.K. exhibit over 15% y-o-y growth in 2021
- Surging healthcare spending has been fuelling the demand in Germany and France
- Increasing demand for vaccination amid COVID-19 fuelling sales in China, Japan, and South Korea
“Some of the leading players are aiming at intensifying their production facilities to cater to the rising demand for vials and prefilled syringes to aid COVID-19 vaccination drives,” says FMI analyst.
Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-5236
Pharmaceutical Unit Dose Packaging Market Players Focusing on Geographic Expansion
As per FMI analysis, some of the leading manufacturing companies within pharmaceutical industry have been aiming at expanding their footprint, especially in remote areas with unmet medical needs. The demand for smaller packaging solutions such as blisters is considerably high in these regions. Furthermore, pharmaceutical unit dose supplying strategy includes getting some medicines in bulk quantities and repackaging them into single or unit dose, using high volume repackaging systems and some manual repackaging machines.
Cost saving is a key benefit of locally repackaging of medicines into unit dose, using high volume automated repackaging systems. Unit Dose Solutions, Inc., Safecor Health, Almac Group are some of the players who are active in repackaging services.